Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Nov-Dec;14(6):1927-1930.
doi: 10.1016/j.dsx.2020.09.035. Epub 2020 Oct 1.

Relation of D-dimer levels of COVID-19 patients with diabetes mellitus

Affiliations
Observational Study

Relation of D-dimer levels of COVID-19 patients with diabetes mellitus

Yogendra Mishra et al. Diabetes Metab Syndr. 2020 Nov-Dec.

Abstract

Background and aims: Diabetes is a frequent comorbidity in patients with Severe COVID-19 infection associated with a worse prognosis. Hypercoagulability with elevation in D-dimer levels has been demonstrated in patients with COVID-19. This study aims to study D-dimer levels in people with diabetes compared to those without diabetes among patients with COVID-19 infection.

Methods: In this observational study 98 moderate and severely ill patients with COVID-19 infection were included at a dedicated COVID hospital. The study group was divided into patients with diabetes and without diabetes. Peak D-dimer was measured in both the groups and compared using appropriate statistical tests.

Results: In our study peak D-dimer levels were 1509 ± 2420 ng/mL (Mean ± SD) in people with diabetes and 515 ± 624 ng/mL (Mean ± SD) in patients without diabetes. Patients with diabetes had higher D-dimer levels which were statistically significant.

Conclusions: This study shows COVID-19 patients with diabetes had significantly higher D-dimer levels. Therefore, it is possible that COVID-19 infection with diabetes is more likely to cause hypercoagulable state with a worse prognosis. However clinical implications of these findings will need to be seen in further studies.

Keywords: COVID-19; D-dimer; Diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart showing enrolment of patients for the study.
Fig. 2
Fig. 2
Box-plots of Peak D-dimer levels in COVID-19 showing a significant difference between people with diabetes and people without diabetes.

References

    1. Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–534. - PMC - PubMed
    1. Coronavirus COVID-19 (2019-nCoV) https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594... [Internet]. [cited 2020 Sep 13]. Available from:
    1. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. Risk factors associated with Acute respiratory distress Syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–943. - PMC - PubMed
    1. Chow N., Fleming-Dutra K., Gierke R., Hall A., Hughes M., Pilishvili T. Preliminary estimates of the prevalence of selected underlying Health conditions among patients with coronavirus disease 2019. MMWR Morb Mortal Wkly Rep. 2020;69:382–386. - PMC - PubMed
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA, J Am Med Assoc. 2020;323:1239–1242. - PubMed

Publication types

Substances